Target intelligence / Profile preview

Marburg virus genomic RNA (MARV RNA)

Target
MARV RNA
Molecular classification
Viral RNA, Nucleic acid
01

Overview

Marburg virus genomic RNA is a single-stranded, negative-sense RNA molecule of approximately 19 kilobases that serves as the genetic blueprint for the Marburg virus (MARV), a highly pathogenic member of the Filoviridae family (NCBI Genome, 2024). The genome encodes seven structural proteins, including the nucleoprotein (NP), VP35, VP40, glycoprotein (GP), VP30, VP24, and the RNA-dependent RNA polymerase (L), which are essential for viral entry, replication, and assembly (Kuhlmann et al., 2018). During the viral life cycle, the genomic RNA acts as a template for the synthesis of viral messenger RNAs and a positive-sense antigenome intermediate (WHO, 2023). As the central component of viral persistence and pathogenesis, MARV RNA is a critical target for therapeutic strategies, including antisense oligonucleotides (e.g., AVI-7288) and small interfering RNAs (e.g., TKM-Marburg) that bind directly to the RNA to prevent translation or induce degradation (Warren et al., 2014; Thi et al., 2015). Additionally, the replication process of this RNA is targeted by nucleoside analogs such as Remdesivir and Galidesivir, which act as alternative substrates for the viral polymerase, leading to premature termination of the nascent RNA strand (Warren et al., 2016; Taylor et al., 2016).

Other names
Marburg virus genomeMARV negative-sense RNAMarburg marburgvirus RNANegative-sense single-stranded RNA genome
02

Mechanism of action

Sequence-specific binding by antisense or siRNA to block translation/degradation, or inhibition of RNA synthesis via nucleoside analog chain termination.

03

Biological functions

Viral replicationViral transcriptionGenetic material storageTemplate for protein synthesis
04

Disease associations

Marburg virus diseaseViral hemorrhagic feverInfection
05

Safety considerations

High mutation rate leading to potential drug resistanceDelivery challenges for nucleic acid therapeutics to target tissuesExtreme pathogenicity requiring BSL-4 containment for researchPotential for off-target effects with antisense technologies
06

Interacting drugs

Remdesivir (GS-5734)

4 more in the full profile.

07

Biomarkers

MARV RNA viral load (RT-PCR)Serum MARV RNA levels

Beyond the preview

Go deeper on Marburg virus genomic RNA (MARV RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marburg virus genomic RNA (MARV RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call